Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “AMIRA PHARMACEUTICALS, INC.”

23 pharma patents match "AMIRA PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 23
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 23 pharmaceutical patents matching "AMIRA PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

23 results for “AMIRA PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 10000456

    Polycyclic compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted

  2. US 9849109

    Autotaxin inhibitors and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

  3. US 9624182

    Compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  4. US 9556133

    Polycyclic LPA1 antagonist and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  5. US 9272990

    Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis

    AMIRA PHARMACEUTICALS, INC. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  6. US 9260416

    Heterocyclic autotaxin inhibitors and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

  7. US 9090573

    Compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  8. US 9000025

    Autotaxin inhibitors and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  9. US 8778983

    Polycyclic compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  10. US 8664220

    Polycyclic compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  11. US 8592402

    Compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  12. US 8541587

    Lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted

  13. US 8455499

    Alkyne antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  14. US 8440707

    Antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted May 14, 2013 · Expires May 9, 2033

    granted

  15. US 8273780

    Polycyclic antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  16. US 8217066

    Compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  17. US 8058300

    Polycyclic antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  18. US 8048902

    Antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted

  19. US 7977359

    5-lipdxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  20. US 7919621

    Tricyclic inhibitors of 5-lipoxygenase

    AMIRA PHARMACEUTICALS, INC. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  21. US 7834037

    5-lipoxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted

  22. US 7795274

    5-lipoxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted

  23. US 7405302

    5-lipoxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.